Particle.news

Download on the App Store

Psilocybin Extends Lifespan in Cells and Mice and Paves Way for Human Trials

Researchers plan early human trials after psilocybin preserved telomeres, reduced oxidative stress, improved DNA repair in preclinical testing.

Image
Image
Image

Overview

  • Psilocybin preserved telomere length and extended cellular lifespan by more than 50% in human lung and skin cells.
  • In aged mice, survival rates improved by roughly 30% to 80% depending on dosing protocols, and treated animals displayed hair regrowth, fewer white hairs and improved fur quality.
  • Mechanistic analyses revealed that psilocybin treatment upregulated SIRT1, downregulated GADD45a and reduced oxidative stress to mitigate cellular senescence.
  • The study’s authors caution that optimal dosing schedules, comprehensive safety profiling and confirmation of causal anti-aging effects in humans remain outstanding.
  • Research teams at Emory University and Baylor College of Medicine are designing early human studies to refine dosing protocols and monitor potential adverse effects.